CLINICAL_TRIALS
trial_result
· 2024-12-12
Clinical Trial Update: Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG) [NA]
Summary
Completed safety and performance evaluation of the ARGOS-IO intraocular system for primary open-angle glaucoma; trial results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Implandata Ophthalmic Products GmbH | Conditions: Primary Open Angle Glaucoma (POAG) | NA | Status: COMPLETED | Results posted: 2024-12-12